SCHEMBL14200031

SCHEMBL14200031

Cc1ccc(C)n1-c1ccc(Cl)c(C(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.51
CTSB P07858 2/20 0.51
MYC P01106 4/20 0.47
NR4A1 P22736 3/20 0.47
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 5/20 0.39
MAPT P10636 5/20 0.39
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
ALOX15 P16050 3/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
POLB P06746 3/20 0.38
KLKB1 P03952 1/20 0.38
ELANE P08246 1/20 0.38
MMP9 P14780 1/20 0.38
DUSP3 P51452 1/20 0.38
PKM P14618 1/20 0.38
NOTUM Q6P988 1/20 0.37
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15871992 0.78 TDP1 (0.59) TDP1CTSBMYCNR4A1ALDH1A1
SCHEMBL7031169 0.78 MYC (0.59) TDP1CTSBMYCNR4A1ALDH1A1
SCHEMBL23245567 0.73 CTSB (0.54) TDP1CTSBMYCNR4A1ALDH1A1
SCHEMBL31406334 0.73 TDP1 (0.54) TDP1CTSBMYCNR4A1ALDH1A1
SCHEMBL31329466 0.73 CTSB (0.54) TDP1CTSBMYCNR4A1ALDH1A1
SCHEMBL10022692 0.73 KMT2A (0.43) ALDH1A1KDM4EMEN1KMT2ANOTUM
SCHEMBL12180526 0.72 MYC (0.58) TDP1CTSBMYCNR4A1ALDH1A1
SCHEMBL2737284 0.71 LMNA (0.50) TDP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL13542787 0.71 MAPT (0.50) TDP1CTSBALDH1A1KDM4EMAPT
SCHEMBL5005129 0.69 MYC (0.59) TDP1CTSBMYCNR4A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778874-B2 Glycopeptide antibiotic monomer derivatives NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2014-07-15 US disclosed
US-20080097078-A1 Antibacterial activity against vancomycin-resistant bacteria SHIONOGI & CO., LTD. (JP) 2008-04-24 US disclosed
US-20080097078-A1 Antibacterial activity against vancomycin-resistant bacteria SHIONOGI & CO., LTD. (JP) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080097078-A1 Antibacterial activity against vancomycin-resistant bacteria CSGALNACT1, MON2, NR2C2 TDP1 4683/4885CTSB 4019/4885MYC 743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.